SCHEMBL4849092

SCHEMBL4849092

COC(=O)C1CC(OC)(OC)CN1C(=O)OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.48
MITF O75030 1/20 0.48
MAPT P10636 1/20 0.48
FKBP1A P62942 1/20 0.45
NPSR1 Q6W5P4 1/20 0.44
PREP P48147 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
HTR2C P28335 1/20 0.43
ALDH1A1 P00352 2/20 0.43
TSHR P16473 2/20 0.43
CYP3A4 P08684 1/20 0.43
CASP1 P29466 1/20 0.43
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849095 1.00 HTT (0.48) HTTMITFMAPTFKBP1ANPSR1
SCHEMBL10741414 0.90 NPC1 (0.46) NPSR1PREPSMN1; SMN2NPC1RAB9A
SCHEMBL12820199 0.89 MITF (0.43) HTTMITFMAPTFKBP1ANPSR1
SCHEMBL18020339 0.87 MITF (0.49) HTTMITFMAPTFKBP1ANPSR1
SCHEMBL2707991 0.86 MITF (0.48) HTTMITFMAPTFKBP1ANPSR1
SCHEMBL204603 0.86 MITF (0.48) HTTMITFMAPTFKBP1ANPSR1
SCHEMBL8298601 0.86 MITF (0.48) HTTMITFMAPTFKBP1ANPSR1
SCHEMBL8279227 0.86 MITF (0.48) HTTMITFMAPTFKBP1ANPSR1
SCHEMBL201195 0.84 HTT (0.47) HTTMITFMAPTFKBP1ANPSR1
SCHEMBL9977347 0.84 HTT (0.47) HTTMITFMAPTFKBP1ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7342012-B2 Inhibitors of αLβ2 mediated cell adhesion MITSUBISHI TANABE PHARMA CORPORATION (JP) 2008-03-11 US disclosed
US-20050148602-A1 Inhibitors of alphaLbeta2 mediated cell adhesion TANABE SEIYAKU CO., LTD. 2005-07-07 US disclosed
US-6897225-B1 Inhibitors of αLβ2 mediated cell adhesion TANABE SEIYAKU CO., LTD. (JP) 2005-05-24 US disclosed
EP-1307455-B1 INHIBITORS OF ALPHA-L BETA-2 MEDIATED CELL ADHESION TANABE SEIYAKU CO (JP) 2005-04-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148602-A1 Inhibitors of alphaLbeta2 mediated cell adhesion ITGB2, ITGA2B, ITGB1 HTT 4603/4885MITF 3629/4885MAPT 2995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.